Alnespirone
Alternative Names: S 20499Latest Information Update: 03 Nov 2003
At a glance
- Originator Servier
- Class
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 03 Nov 2003 Discontinued - Phase-II for Anxiety disorders in France (unspecified route)
- 03 Nov 2003 Discontinued - Phase-II for Depression in France (unspecified route)
- 04 Dec 1998 No-Development-Reported for Anxiety disorders in France (Unknown route)